We are live on ! Find out more
EW

Evoke Wealth Portfolio holdings

AUM $5.57B
1-Year Est. Return 23.85%
This Fund
S&P 500
This Quarter Est. Return
+16.6%
1 Year Est. Return
+23.85%
3 Year Est. Return
+55.14%
5 Year Est. Return
+52.16%
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$329M
Cap. Flow
+$206M
Cap. Flow %
19.93%
Top 10 Hldgs %
70.15%
Holding
1,259
New
134
Increased
270
Reduced
422
Closed
121

Sector Composition

Rank Sector Weight
1 Financials 4.9%
2 Technology 4.12%
3 Communication Services 2.02%
4 Healthcare 1.77%
5 Energy 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYX icon
1201
NCR Voyix
VYX
$1.12B
$0 ﹤0.01%
39
WAB icon
1202
Wabtec
WAB
$49.4B
-52
Closed -$2.5K
WBD icon
1203
Warner Bros
WBD
$63.9B
$0 ﹤0.01%
7
WIT icon
1204
Wipro
WIT
$19.3B
$0 ﹤0.01%
144
ZBRA icon
1205
Zebra Technologies
ZBRA
$13.7B
-30
Closed -$5.51K
VRN
1206
DELISTED
Veren
VRN
$0 ﹤0.01%
+236
New +$326
BEST
1207
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$0 ﹤0.01%
+6
New +$616
AXNX
1208
DELISTED
Axonics, Inc. Common Stock
AXNX
-234
Closed -$5.95K
SRCL
1209
DELISTED
Stericycle Inc
SRCL
$0 ﹤0.01%
6
WRK
1210
DELISTED
WestRock Company
WRK
-24
Closed -$665
DCPH
1211
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-34
Closed -$1.4K
AVGR
1212
DELISTED
Avinger, Inc. Common Stock
AVGR
0
FEI
1213
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
-658
Closed -$2.91K
CBD
1214
DELISTED
Companhia Brasileira de Distribuicao
CBD
-126
Closed -$1.59K
CBAY
1215
DELISTED
Cymabay Therapeutics
CBAY
-1,015
Closed -$1.5K
LTHM
1216
DELISTED
Livent Corporation
LTHM
$0 ﹤0.01%
15
VRTV
1217
DELISTED
VERITIV CORPORATION
VRTV
-1
Closed -$8
RAD
1218
DELISTED
Rite Aid Corporation
RAD
-23
Closed -$345
RETA
1219
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-43
Closed -$6.21K
ARNC
1220
DELISTED
Arconic Corporation
ARNC
$0 ﹤0.01%
+30
New +$351
CS
1221
DELISTED
Credit Suisse Group
CS
$0 ﹤0.01%
10
-109
-92% -$979
SJR
1222
DELISTED
Shaw Communications Inc.
SJR
$0 ﹤0.01%
18
-1
-5% -$17
AUY
1223
DELISTED
Yamana Gold, Inc.
AUY
$0 ﹤0.01%
53
+26
+96% +$124
CAJ
1224
DELISTED
Canon, Inc.
CAJ
$0 ﹤0.01%
24
+2
+9% +$41
ABMD
1225
DELISTED
Abiomed Inc
ABMD
-3
Closed -$435

Similar funds

Evoke Wealth's Q2 2020 Portfolio in Review

As of Q2 2020, Evoke Wealth held 1,259 positions worth $1.03B, up 47% from $703M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Evoke Wealth deployed $206M of net new capital in Q2 2020, opening 134 new positions and adding to 270 existing holdings. Its largest new stake was Invesco High Yield Equity Dividend Achievers ETF: 80,000 shares worth $1.15M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, down from 6.9% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was TPG RE Finance Trust, an estimated $5.77M trimmed.

  • Evoke Wealth's largest Q2 2020 buy was Invesco High Yield Equity Dividend Achievers ETF: 80,000 shares worth $1.15M.
  • Evoke Wealth added most to RPAR Risk Parity ETF in Q2 2020, an estimated $154M increase.
  • Evoke Wealth's biggest Q2 2020 reduction was TPG RE Finance Trust, cutting an estimated $5.77M.
  • Evoke Wealth fully exited WisdomTree Europe Hedged Equity Fund in Q2 2020, selling an estimated $953K.
  • Evoke Wealth's ten largest holdings make up 70% of its $1.03B portfolio in Q2 2020.
  • Evoke Wealth opened 134 new positions and closed 121 in Q2 2020.
  • Evoke Wealth's portfolio value rose 47% quarter-over-quarter to $1.03B.

Based on Evoke Wealth's 13F filing for Q2 2020, filed 10 Aug 2020.